An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India

BACKGROUND: Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbam...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS Negl Trop Dis
Главные авторы: Jambulingam, Purushothaman, Kuttiatt, Vijesh Sreedhar, Krishnamoorthy, Kaliannagounder, Subramanian, Swaminathan, Srividya, Adinarayanan, Raju, Hari Kishan K., Rahi, Manju, Somani, Roopali K., Suryaprakash, Mallanna K., Dwivedi, Gangeshwar P., Weil, Gary J.
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2021
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7909694/
https://ncbi.nlm.nih.gov/pubmed/33591979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0009069
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы